Hoppa till innehåll
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Avancerad
  • Acarbose was effective in main...
  • Hänvisa
  • Textmeddelande
  • Skicka per e-post
  • Skriv ut
  • Exportera posten
    • Exportera till: RefWorks
    • Exportera till: EndNoteWeb
    • Exportera till: EndNote
  • Permanent länk
Acarbose was effective in maintaining glycemic control in type 2 diabetes mellitus but was associated with adverse effects

Acarbose was effective in maintaining glycemic control in type 2 diabetes mellitus but was associated with adverse effects

Bibliografiska uppgifter
Huvudupphovsmän: Holman, R, Dinneen, S
Materialtyp: Journal article
Språk:English
Publicerad: 1999
  • Beståndsuppgifter
  • Beskrivning
  • Liknande verk
  • Katalogiseringsuppgifter

Liknande verk

  • The effect of combination therapy of sulfonylurea, metformin, and acarbose in type 2 diabetes mellitus patients
    av: Tri Murti Andayani,, et al.
    Publicerad: (2009-12-01)
  • A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44)
    av: Holman, R, et al.
    Publicerad: (1999)
  • Effects of the addition of acarbose to insulin and non-insulin regimens in veterans with type 2 diabetes mellitus
    av: Wettergreen SA, et al.
    Publicerad: (2016-12-01)
  • Improved glycemic control by acarbose therapy in hypertensive diabetic patients: effects on blood pressure and hormonal parameters
    av: P. Rosenbaum, et al.
    Publicerad: (2002-08-01)
  • Impact of baseline characteristics on glycemic effects of add‐on saxagliptin or acarbose to metformin therapy: Subgroup analysis of the SMART study in Chinese patients with type 2 diabetes mellitus
    av: Hui Fang, et al.
    Publicerad: (2020-07-01)

Sökalternativ

  • Sökhistorik
  • Avancerad sökning

Sök mera

  • Bläddra i katalogen
  • Bläddra alfabetiskt
  • Utforska kanaler
  • Kursböcker
  • Nytt i katalogen

Behöver du hjälp?

  • Söktips
  • Fråga biblioteket
  • Vanliga frågor